Table 1 Baseline patient demographics and disease characteristics
Characteristics | Patients (N=36) |
|---|---|
Age, years | 62 (28-75) |
Sex | Â |
 Male | 23 (63.9) |
 Female | 13 (36.1) |
ECOG performance status | Â |
 0 | 28 (77.8) |
 1 | 8 (22.2) |
Type of tumor | Â |
 Primary | 24 (66.7) |
 Recurrent | 12 (33.3) |
Size of primary tumor, cm | Â |
 ≤5 | 14 (38.9) |
 >5 | 22 (61.1) |
Lymph node status | Â |
 Negative | 14 (38.9) |
 Positive | 22 (61.1) |
TNM stage | Â |
 II | 3 (8.3) |
 III | 33 (91.7) |
CEA, ng/mL | 4 (1-25) |
CA19-9, ng/mL | 1243 (2->12,000) |
TMB status | Â |
 High | 15 (41.7) |
 Low | 21 (58.3) |
PD-L1 result | Â |
 Negative | 30 (83.3) |
 Positive | 6 (16.7) |
Microsatellite status | Â |
 MSI | 4 (11.1) |
 MSS | 32 (88.9) |
Multifocal lesions | Â |
 Single | 20 (55.6) |
 Multiple | 16 (44.4) |
Albumin, g/L | 36 (28-49) |
TBIL, μmol/L | 14.3 (3.5-33.0) |
Cirrhosis | Â |
 Yes | 11 (30.6) |
 No | 25 (69.4) |